0000899243-23-008013.txt : 20230310
0000899243-23-008013.hdr.sgml : 20230310
20230310161101
ACCESSION NUMBER: 0000899243-23-008013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230310
DATE AS OF CHANGE: 20230310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMPSON TODD E
CENTRAL INDEX KEY: 0001216477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23723716
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-09
0
0001060736
Seagen Inc.
SGEN
0001216477
SIMPSON TODD E
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Financial Officer
Common Stock
2023-03-09
4
M
0
42793
45.30
A
159978
D
Common Stock
2023-03-09
4
S
0
10262
175.89
D
149716
D
Common Stock
2023-03-09
4
S
0
26449
176.71
D
123267
D
Common Stock
2023-03-09
4
S
0
6082
177.37
D
117185
D
Non-Qualified Stock Option (right to buy)
45.30
2023-03-09
4
M
0
42793
0.00
D
2026-08-27
Common Stock
42793
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of common stock executed in multiple transactions at prices ranging from $175.19 to $176.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $176.19 to $177.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $177.19 to $177.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested at a rate of 25% on 8/27/17 and monthly thereafter until all the options were fully vested on 8/27/20.
By: /s/ Jennifer Prosba For: Todd Simpson
2023-03-10